Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

NCT04655313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Plaque Psoriasis

Interventions

DRUG: ARQ-151 cream 0.3%

Sponsor

Arcutis Biotherapeutics, Inc.